Sotera Health (NYSE:SHC) Announces Quarterly Earnings Results

Sotera Health (NYSE:SHCGet Rating) posted its quarterly earnings data on Thursday. The company reported $0.27 EPS for the quarter, topping the consensus estimate of $0.23 by $0.04, reports. The company had revenue of $266.40 million during the quarter, compared to analyst estimates of $256.30 million. Sotera Health had a net margin of 14.30% and a return on equity of 42.65%. Sotera Health’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.25 earnings per share. Sotera Health updated its FY22 guidance to $0.93-0.97 EPS and its FY 2022 guidance to $0.93-$0.97 EPS.

Sotera Health Trading Up 0.9 %

NYSE:SHC traded up $0.16 during midday trading on Friday, hitting $18.53. The stock had a trading volume of 621,680 shares, compared to its average volume of 781,029. The company has a quick ratio of 2.27, a current ratio of 2.58 and a debt-to-equity ratio of 2.78. The stock has a 50-day moving average of $19.96 and a 200 day moving average of $20.61. The company has a market capitalization of $5.24 billion, a price-to-earnings ratio of 37.82 and a beta of 0.35. Sotera Health has a one year low of $17.73 and a one year high of $27.38.

Analyst Ratings Changes

Several equities analysts recently commented on SHC shares. Barclays cut their price target on shares of Sotera Health from $24.00 to $22.00 and set an “equal weight” rating on the stock in a report on Wednesday, July 13th. Wolfe Research cut Sotera Health from an “outperform” rating to a “peer perform” rating and set a $26.00 target price on the stock. in a research note on Thursday, June 9th. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $25.83.

Institutional Trading of Sotera Health

Several institutional investors and hedge funds have recently made changes to their positions in SHC. MetLife Investment Management LLC purchased a new position in Sotera Health during the 1st quarter valued at about $139,000. Federated Hermes Inc. purchased a new position in Sotera Health during the first quarter valued at approximately $157,000. PNC Financial Services Group Inc. bought a new position in Sotera Health in the first quarter worth approximately $317,000. First Trust Advisors LP purchased a new stake in Sotera Health during the first quarter worth $583,000. Finally, Sei Investments Co. boosted its position in Sotera Health by 32.8% during the 1st quarter. Sei Investments Co. now owns 36,970 shares of the company’s stock valued at $801,000 after acquiring an additional 9,128 shares in the last quarter. 87.44% of the stock is currently owned by institutional investors.

Sotera Health Company Profile

(Get Rating)

Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries.

Recommended Stories

Earnings History for Sotera Health (NYSE:SHC)

Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with's FREE daily email newsletter.